Samsung Biologics to launch takeover bid for PolyPeptide in September

Samsung Biologics will launch its takeover offer ​for Swiss contract drugmaker ​PolyPeptide Group in September, the ⁠South Korean company said ​in an offer prospectus on ​Monday.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。